What are the differences between Molecular circulating tumor DNA (ctDNA) testing and minimal residual disease (MRD) testing?

Now presenting Dr. @Joshua_Reuss!

#LungCancer #TargetedTherapies #TrueOrFalse #Molecularprofiling #MRDTesting #ctDNATesting

Recovery to Renaissance: The Diagnostics Year in Review 2025 Volume 13, Issue 4 | January 29, 2026

open.substack.com/pub/sensitiv...

#sensitiveandspecific #diagnostics #yearinreview #diagnostictesting #healthcare #alzheimers #parkinsons #MRDtesting #MCED #MegaDxIndex #diagnosticscompanies #industryleaders #genomics #multiomics #proteomics #AI #Regulation #FDA #reimbursement #innovation

Kyle’s experience with stage IV colon cancer underscores the role of early detection and personalized care. With the help of Signatera™ MRD testing, Kyle’s care team identified recurrence before imaging could and took swift action.

See his full story: https://ow.ly/czIF50XAbPg
#MRDtesting #Natera

Meet Holly, Clear Cell Ovarian Cancer Survivor and Signatera Patient Clear cell ovarian cancer can return—even years after treatment. #Signatera, Natera’s personalized MRD (ctDNA) test, looks for tiny traces of tumor DNA between scans and may detect molecular signs mon

"Signatera gives me the power to go on with my life instead of constantly wondering ‘what-if.’"

Two days after a visit to the emergency room, Holly underwent surgery and received a rare ovarian cancer diagnosis.

www.natera.com/resource-lib...

#OvarianCancerAwareness #Signatera #MRDtesting #Natera

Minimal Residual Disease Testing Market Projected to Hit USD 8.42 Billion by 2032, at a Exceptional CAGR 12.55% - Industry Today Minimal Residual Disease Testing Market CAGR is expected to be around 12.55% during the forecast period 2025 - 2032

🧪 Minimal Residual Disease Testing Market is booming—expected to hit $84.2B by 2032 with a whopping 12.55% CAGR 🔬

#CancerDiagnostics #MRDTesting #OncologyInnovation

industrytoday.co.uk/health_and_s...

Adanma Ayanambakkam, MD, genitourinary oncologist at Stephenson Cancer Center shares recent data on the prognostic value of ctDNA-based MRD detection in patients with upper tract urothelial cancer.
#MRDTesting #Natera #Signatera

Watch the video: www.natera.com/resource-lib...

Last week, the partners of the Innovative Innovative Health Initiative (IHI) GUIDE.MRD consortium gathered in Nice, 🇫🇷 , for their third annual general assembly. Ana Martins, Ph.D. and Zorana Maravic represented DiCE.
#GUIDEMRD #GeneralAssembly
#MRDTesting
@ihieurope.bsky.social

Renowned GI Oncologist Discusses MRD Testing and the Future of Cancer Detection In this episode, Dr. Lewis joins Theral in our ongoing series on minimal residual disease (MRD) testing, a revolutionary blood test that is helping detect residual cancer causing a paradigm shift in p...

Renowned GI Oncologist Mark Lewis Discusses MRD Testing and the Future of Cancer Detection

www.mendelspod.com/p/renowned-g...

@intermountain.bsky.social
#MRDtesting #ctDNA #oncology #liquidbiopsy #GALAXYstud